TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.

Robine Donken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.